Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
88,628,011
-
Share change
-
-3,076,702
-
Total reported value
-
$10,894,534,004
-
Put/Call ratio
-
142%
-
Price per share
-
$122.95
-
Number of holders
-
340
-
Value change
-
-$350,597,450
-
Number of buys
-
182
-
Number of sells
-
130
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q3 2018
As of 30 Sep 2018,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
340 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,628,011 shares.
The largest 10 holders included
FMR LLC, Vanguard Group Inc, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., PERCEPTIVE ADVISORS LLC, BB BIOTECH AG, Invesco Ltd., FRANKLIN RESOURCES INC, and Artisan Partners Limited Partnership.
This page lists
340
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.